SEARCH

SEARCH BY CITATION

References

  • ABI-GERGES, N., PHILP, K., POLLARD, C., WAKEFIELD, I., HAMMOND, T.G. & VALENTIN, J.P. (2004a). Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes. Fundam. Clin. Pharmacol., 18, 139151.
  • ABI-GERGES, N., SMALL, B.G., LAWRENCE, C.L., HAMMOND, T.G., VALENTIN, J.P. & POLLARD, C.E. (2004b). Evidence for gender differences in electrophysiological properties of canine Purkinje fibres. Br. J. Pharmacol., 142, 12551264.
  • ANON. (1997). Committee for Proprietary Medical Products (CPMP). Points to consider: The assessment of the potential of QT interval prolongation by non-cardiovascular medicinal products. The European Agency for the evaluation of medicinal products. London, 17 December. Reference CPMP/ICH/986/96.
  • ANON. (2005a). ICH E14 Note for guidance on the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. London, 25 May. Reference CHMP/ICH/2/04.
  • ANON. (2005b). ICH S7B Note for guidance on the nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. London, 25 May. Reference CHMP/ICH/423/02.
  • BILICZKI, P., VIRAG, L., IOST, N., PAPP, J.G. & VARRO, A. (2002). Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve. Br. J. Pharmacol., 137, 361368.
  • BOSCH, R.F., GASPO, R., BUSCH, A.E., LANG, H.J., LI, G.R. & NATTEL, S. (1998). Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc. Res., 38, 441450.
  • CHIANG, C.E. (2004). Congenital and acquired long QT syndrome. Current concepts and management. Cardiol. Rev., 12, 222234.
  • GOGELEIN, H., BRUGGEMANN, A., GERLACH, U., BRENDEL, J. & BUSCH, A.E. (2000). Inhibition of IKs channels by HMR 1556. Naunyn. Schmiedebergs Arch. Pharmacol., 362, 480488.
  • GRALINSKI, M.R. (2003). The dog's role in the preclinical assessment of QT interval prolongation. Toxicol. Pathol., 31 (Suppl), 1116.
  • HAN, W., WANG, Z. & NATTEL, S. (2001). Slow delayed rectifier current and repolarization in canine cardiac Purkinje cells. Am. J. Physiol. Heart Circ. Physiol., 280, H1075H1080.
  • JAMES, A.F., CHOISY, S.C.M. & HANCOX, J.C. (2005). Recent advances in understanding sex differences in cardiac repolarization. Prog. Biophys. Mol. Biol., in press (doi: 10.1016/j.pbiomolbio.2005.05.010).
  • KEATING, M.T. & SANGUINETTI, M.C. (2001). Molecular and cellular mechanisms of cardiac arrhythmias. Cell, 104, 569580.
  • LENGYEL, C., DEZSI, L., BILICZKI, P., HORVATH, C., VIRAG, L., IOST, N., NEMETH, M., TALOSI, L., PAPP, J.G. & VARRO, A. (2004). Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk. Br. J. Pharmacol., 143, 152158.
  • LENGYEL, C., IOST, N., VIRAG, L., VARRO, A., LATHROP, D.A. & PAPP, J.G. (2001). Pharmacological block of the slow component of the outward delayed rectifier current (IKs) fails to lengthen rabbit ventricular muscle QT(c) and action potential duration. Br. J. Pharmacol., 132, 101110.
  • LIU, G.X., DERST, C., SCHLICHTHORL, G., HEINEN, S., SEEBOHM, G., BRUGGEMANN, A., KUMMER, W., VEH, R.W., DAUT, J. & PREISIG-MULLER, R. (2001). Comparison of cloned Kir2 channels with native inward rectifier K+ channels from guinea-pig cardiomyocytes. J. Physiol., 532, 115126.
  • LIU, X.K., KATCHMAN, A., DRICI, M.D., EBERT, S.N., DUCIC, I., MORAD, M. & WOOSLEY, R.L. (1998). Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J. Pharmacol. Exp. Ther., 285, 672679.
  • LU, H.R., VLAMINCKX, E., VAN DE WATER, A. & GALLACHER, D.J. (2005). Both β-adrenergic receptor stimulation and cardiac tissue type have important roles in elucidating the functional effects of IKs channel blockers in vitro. J. Pharmacol. Toxicol. Methods, 51, 8190.
  • NAKAGAWA, M., OOIE, T., OU, B., ICHINOSE, M., TAKAHASHI, M., HARA, M., YONEMOCHI, H. & SAIKAWA, T. (2005). Gender differences in autonomic modulation of ventricular repolarization in humans. J. Cardiovasc. Electrophysiol., 16, 278284.
  • NATTEL, S. & QUANTZ, M.A. (1988). Pharmacological response of quinidine-induced early afterdepolarizations in canine Purkinje fibres: insights into underlying ionic mechanisms. Cardiovasc. Res., 22, 808817.
  • NATTEL, S. & SINGH, B.N. (1999). Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions. Am. J. Cardiol., 84, 11R19R.
  • PLASTER, N.M., TAWIL, R., TRISTANI-FIROUZI, M., CANUN, S., BENDAHHOU, S., TSUNODA, A., DONALDSON, M.R., IANNACCONE, S.T., BRUNT, E., BAROHN, R., CLARK, J., DEYMEER, F., GEORGE JR, A.L., FISH, F.A., HAHN, A., NITU, A., OZDEMIR, C., SERDAROGLU, P., SUBRAMONY, S.H., WOLFE, G., FU, Y.H. & PTACEK, L.J. (2001). Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell, 105, 511519.
  • REDFERN, W.S., CARLSSON, L., DAVIS, A.S., LYNCH, W.G., MACKENZIE, I., PALETHORPE, S., SIEGL, P.K., STRANG, I., SULLIVAN, A.T., WALLIS, R., CAMM, A.J. & HAMMOND, T.G. (2003). Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res., 58, 3245.
  • RODRIGUEZ, I., KILBORN, M.J., LIU, X.K., PEZZULLO, J.C. & WOOSLEY, R.L. (2001). Drug-induced QT prolongation in women during the menstrual cycle. JAMA, 285, 13221326.
  • SCHREIECK, J., WANG, Y., GJINI, V., KORTH, M., ZRENNER, B., SCHOMIG, A. & SCHMITT, C. (1997). Differential effect of β-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B. J. Cardiovasc. Electrophysiol., 8, 14201430.
  • SHIMIZU, W. & ANTZELEVITCH, C. (1998). Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation, 98, 23142322.
  • SHUBA, Y.M., DEGTIAR, V.E., OSIPENKO, V.N., NAIDENOV, V.G. & WOOSLEY, R.L. (2001). Testosterone-mediated modulation of HERG blockade by proarrhythmic agents. Biochem. Pharm., 62, 4149.
  • STENGL, M., VOLDERS, P.G., THOMSEN, M.B., SPATJENS, R.L., SIPIDO, K.R. & VOS, M.A. (2003). Accumulation of IKs in canine ventricular myocytes. J. Physiol., 551 (Part 3), 777786.
  • STRAUS, S.M.J.M, STURKENBOOM, M.C.J.M, BLEUMINK, G.S., DIELEMAN, J.P, VAN DER LEI, J., DE GRAEFF, P.A., KINGMA, J.H. & STRICKER, B.H.CH. (2005). Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur. Heart J., 26, 20072012.
  • SUN, Z.Q., THOMAS, G.P. & ANTZELEVITCH, C. (2001). Chromanol 293B inhibits slowly activating delayed rectifier and transient outward currents in canine left ventricular myocytes. J. Cardiovasc. Electrophysiol., 12, 472478.
  • TAMARGO, J., CABALLERO, R., GOMEZ, R., VALENZUELA, C. & DELPON, E. (2004). Pharmacology of cardiac potassium channels. Cardiovasc. Res., 62, 933.
  • VARRO, A., BALATI, B., IOST, N., TAKACS, J., VIRAG, L., LATHROP, D.A., CSABA, L., TALOSI, L. & PAPP, J.G. (2000). The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization. J. Physiol., 523 (Part 1), 6781.
  • VOLDERS, P.G., STENGL, M., VAN OPSTAL, J.M., GERLACH, U., SPATJENS, R.L., BEEKMAN, J.D., SIPIDO, K.R. & VOS, M.A. (2003). Probing the contribution of IKs to canine ventricular repolarization: key role for β-adrenergic receptor stimulation. Circulation, 107, 27532760.
  • ZICHA, S., MOSS, I., ALLEN, B., VARRO, A., PAPP, J., DUMAINE, R., ANTZELEVICH, C. & NATTEL, S. (2003). Molecular basis of species-specific expression of repolarizing K+ currents in the heart. Am. J. Physiol. Heart Circ. Physiol., 285, H1641H1649.